Patents by Inventor Mike Stelmah

Mike Stelmah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220401302
    Abstract: The present disclosure provides aseptic vial piercing and sterilization systems, and methods of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized primary container including a first end, a first cavity, a second end with an opening in communication with the first cavity, a septum at least partially sealing the opening, and a product within the first cavity. The systems and methods include an injection assembly including a first end portion of a hollow flowpath forming member. The injection assembly and the primary container may be assembled in a non-sterile environment to form a second cavity extending about the first end portion of the flowpath forming member and to the primary container. The second cavity may then be selectively sterilized in a non-deleterious manner to the product to allow the first end portion to aseptically pierce the septum to extend into the first cavity.
    Type: Application
    Filed: June 29, 2022
    Publication date: December 22, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Rachel Paige ARNOTT, Bart E. BURGESS, Michael CUPICHA, Alexei GORALTCHOUK, Bryan GRYGUS, Mike STELMAH
  • Patent number: 11406565
    Abstract: The present disclosure provides aseptic vial piercing and sterilization systems, and methods of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized primary container including a first end, a first cavity, a second end with an opening in communication with the first cavity, a septum at least partially sealing the opening, and a product within the first cavity. The systems and methods include an injection assembly including a first end portion of a hollow flowpath forming member. The injection assembly and the primary container may be assembled in a non-sterile environment to form a second cavity extending about the first end portion of the flowpath forming member and to the primary container. The second cavity may then be selectively sterilized in a non-deleterious manner to the product to allow the first end portion to aseptically pierce the septum to extend into the first cavity.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: August 9, 2022
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Rachel Paige Arnott, Bart E. Burgess, Michael Cupicha, Alexei Goraltchouk, Bryan Grygus, Mike Stelmah
  • Patent number: 10869966
    Abstract: A syringe system, piston seal systems, stopper systems, and methods for assembling and using the syringe systems. The piston seal system including a piston seal member and a piston head member. The injection system including a container, a piston seal system positioned within the container, and a stopper system coupled to an end of the container. The method of assembling an injection system, the method includes obtaining a container, a piston seal system, and a stopper system. The method also includes inserting the piston seal system into a cavity within the container. The method further includes securing the stopper system at an end of the container in an opening of the cavity. Methods of using the syringe system, piston seal systems, and stopper systems are also disclosed.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: December 22, 2020
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Michael Cupicha, Alexei Goraltchouk, Ian Hart, Mike Stelmah
  • Patent number: 10182969
    Abstract: The present disclosure provides aseptic vial piercing and sterilization systems, and methods of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized primary container including a first end, a first cavity, a second end with an opening in communication with the first cavity, a septum at least partially sealing the opening, and a product within the first cavity. The systems and methods include an injection assembly including a first end portion of a hollow flowpath forming member. The injection assembly and the primary container may be assembled in a non-sterile environment to form a second cavity extending about the first end portion of the flowpath forming member and to the primary container. The second cavity may then be selectively sterilized in a non-deleterious manner to the product to allow the first end portion to aseptically pierce the septum to extend into the first cavity.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: January 22, 2019
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Rachel Paige Arnott, Bart E. Burgess, Michael Cupicha, Alexei Goraltchouk, Bryan Grygus, Mike Stelmah